ClinicalTrials.gg
Not yet recruitingNCT06658561Updated Oct 26, 2024

Efficacy and Safety Research of Cold Snare Polypectomy and Hot Snare Polypectomy in the Treatment of 4-9 mm Diameter Colorectal 0-Isp and 0-Ip Polyps: a Prospective, Multicenter, Randomized Controlled Study(FAST -REST Study)

An interventional study of cold snare polypectomy and hot snare polypectomy in Cold Snare Resection, Hot Snare Resection and Polyps of Colon, sponsored by Ruijin Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-10-26.

Sponsored by Ruijin Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
982
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study will evaluate the efficacy and safety of cold snare polypectomy(CSP) and hot snare polypectomy(HSP) in the treatment of colorectal 4-9mm 0-Isp and 0-Ip polyps, and compare the complete resection rate, postoperative late bleeding rate, intraoperative bleeding rate, en bloc resection rate, operation time and the number of metal clips used. The conclusion of this study will help clinical doctor develop more effective resection strategies for colorectal 0-Isp and 0-Ip polyps, and provide more effective treatment for patients.

Read the detailed description

Colorectal polyps are one of the precancerous lesions of colorectal cancer, 60-80% of which eventually become advanced colorectal cancer. Therefore, early resection of colorectal polyps can effectively reduce the incidence of colorectal cancer. Polyps under white light are judged mainly according to the shape, size and color of polyps. At present, the Paris classification is often used to divide 0-I uplifted polyps into sessile polyps (0-Is), sessile-pedunculated polyps (0-Isp) and pedunculated polyps (0-Ip). It is generally believed that there are thick arteries in 0-Ip polyps, especially thick pedunculated polyps, which are prone to uncontrollable bleeding during operation. 0-Is polyps have small scattered blood vessels and low intraoperative bleeding risk, while the morphological and structural characteristics of 0-Isp polyps are between the two. The current guidelines recommend HSP for 0-Isp and 0-Ip polyps \<1 cm, but the internal blood vessels of these polyps are not thick. There is no guidance on whether they can be resected by CSP method, and there is a lack of prospective large sample clinical research. This study will include0-Isp /0-Ip polyps \<1cm, and observe the safety and effectiveness of CSP for the above polyp resection , so as to provide reference for the clinical treatment of colorectal polyps.

02

Conditions studied

  • Cold Snare Resection
  • Hot Snare Resection
  • Polyps of Colon

Browse trials for

Keywords

  • cold snare resection
  • hot snare resection
  • colorectal Polyps
03

In context

Colonic Polyps

377 studies on the registry are indexed under Colonic Polyps; 57 are open to participants now.

This study's planned enrollment of 982 is above the median of 274 across 250 interventional studies indexed under Colonic Polyps.

Browse Colonic Polyps studies →

Lead sponsor

Ruijin Hospital is the lead sponsor of 679 studies on the registry; 387 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age: 18-80 years old, male or female
  2. At least one polyp with size of 4-9 mm 0-Isp or 0-Ip is found during colonoscopy
  3. Voluntarily sign for endoscopic treatment

Exclusion criteria

Exclusion Criteria:

  1. Boston Bowel Preparation Scale\<6 points.
  2. Patients who receive antiplatelet/anticoagulant therapy within 5 days before polypectomy.
  3. Participants with a to colonoscopy and polypectomy.
  4. Patients with inflammatory bowel disease or gastrointestinal polyposis.
  5. Lesions with submucosal invasion and those suspected of being cancerous at the preprocedural diagnostic evaluation.
  6. Patients with pregnancy.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
982 participants (estimated)

Study arms

  • Other
    cold snare polypectomy group

    1. Rotate the lens body to make the polyp at about 6 o'clock. 2. Place the special cold snare in the normal mucosa 1-2mm away from the polyp edge. 3. Tighten the snare at a constant speed and gently lift it up. 4. Excision. 5. According to the polyp size, use the colonoscope suction channel or directly use the snare to pull out the tissue for further pathological examination. 6. Piecemeal resection will be performed if the en-bloc resection fails.

    Procedure: cold snare polypectomy

  • Other
    hot snare polypectomy group

    1. Rotate the lens body to make the polyp at about 6 o'clock. 2. According to evaluation of the polyps, directly place the snare on the edge of the polyp including a clear margin of normal tissue (1-2 mm) or after submucosal injection. 3. Tighten the snare at a constant speed and gently lift it up. 4. Use the electrocoagulation and electroscission mode, power on for several seconds until the polyp is cut off. 5. According to the polyp size, use the colonoscope suction channel or directly use the snare to pull out the tissue for further pathological examination. 6. Piecemeal resection will be performed if the en-bloc resection fails.

    Procedure: hot snare polypectomy

Interventions

  • Procedurecold snare polypectomy

    Place the special cold snare in the normal mucosa 1-2mm away from the polyp edge. Tighten the snare at a constant speed and gently lift it up and then excision.

    Also known as: CSP

  • Procedurehot snare polypectomy

    According to evaluation of the polyps, directly place the snare on the edge of the polyp including a clear margin of normal tissue (1-2 mm) or after submucosal injection. Tighten the snare at a constant speed and gently lift it up.Use the electrocoagulation and electroscission mode, power on for several seconds until the polyp is cut off.

    Also known as: HSP

06

What researchers measure

Primary outcomes

  1. Complete resection rate

    The polyps and the two biopsies from the margin will be sent to the pathologist for further analysis. Two independent experienced pathologists will evaluate the samples separately and both are blinded to the technique performed for polypectomy. Complete resection rate is defined as the negative pathological evaluation of two biopsies obtained from the margin.

    Time frame: Up to 5-7 days from operation day

Secondary outcomes

  1. Postoperative delayed bleeding rate

    Incidence of bleeding requiring endoscopic hemostasis intervention within 14 days after surgery

    Time frame: Up to 14 days from operation day

  2. Intraoperative bleeding rate

    Immediate bleeding is defined as bleeding persists \>60s after polypectomy according to the ESGE recommendations (2017) and requires for endoscopic intervention.

    Time frame: Up to 1 minute from the time the polyp is resected

  3. En bloc resection rate

    The lesion is removed at one time, and the integrity of the specimen is maintained

    Time frame: Up to 7 days when the pathologists finish the evaluations.

  4. Operation time

    CSP: the time from the time the snare exits the working channel to leaving the wound. Hsp: time from the injection needle leaving the working channel to leaving the wound

    Time frame: From the snare/ injection needle exits the working channel to leaving the wound.

  5. Other related postoperative complications

    Perforation, infection, electrocoagulation syndrome, etc

    Time frame: Up to 48 Hours from the time the polyp is resected

  6. Number of metal clips used

    Whether metal clips are used for hemostasis, and the number of metal clips

    Time frame: The time when the operation is completed

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06658561
Lead sponsor
Ruijin Hospital
Collaborators
Jinshan Hospital Fudan University, Second Affiliated Hospital of Soochow University, The Third People's Hospital Yunnan, People's Hospital Mojiang, Shanghai Yueyang Integrated Medicine Hospital, Huadong Hospital
Responsible party
ZOU DUOWU (Director of Gastroenterology Department, Ruijin Hospital) — Principal investigator
First posted
Oct 26, 2024
Start date
Oct 15, 2024 (estimated)
Primary completion
Feb 1, 2026 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
Oct 26, 2024

Study contacts

Taojing Ran, MD
Contact
rantaojing@163.com
8615601942397
Duowu Zou, PHD/MD
principal investigator · Ruijin Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion